Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
23,519,400
-
Share change
-
-822,775
-
Total reported value
-
$68,667,507
-
Price per share
-
$2.92
-
Number of holders
-
89
-
Value change
-
-$4,346,817
-
Number of buys
-
35
-
Number of sells
-
46
Institutional Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q4 2018
As of 31 Dec 2018,
BELLICUM PHARMACEUTICALS INC - COM (BLCM) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,519,400 shares.
The largest 10 holders included
JPMORGAN CHASE & CO, BlackRock Inc., BAKER BROS. ADVISORS LP, Vanguard Group Inc, FRAZIER MANAGEMENT LLC, ARK Investment Management LLC, FARALLON CAPITAL MANAGEMENT LLC, WASATCH ADVISORS INC, FMR LLC, and STATE STREET CORP.
This page lists
89
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.